Intestinal smooth muscle dysfunction develops postnatally in cystic fibrosis mice

Journal of Pediatric Gastroenterology and Nutrition

Volumn 55, Issue 6, 2012, Pages 689-694

  De Lisle, Robert C ^a   Meldi, Lauren ^a   Mueller, Racquel ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Cyclooxygenase; Hydroxyprostaglandin dehydrogenase; Phospholipase A2; Prostaglandin; Prostaglandin reductase 1; Small intestinal bacterial overgrowth

Indexed keywords

GAG PROTEIN; HPGD PROTEIN; ICOSANOID; MUSCLE PROTEIN; PLA2G4C PROTEIN; PLA2G5 PROTEIN; PROTEIN P16; PTGR1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL OVERGROWTH; CHOLINERGIC STIMULATION; CONTROLLED STUDY; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MOUSE; ENZYME IMMUNOASSAY; GENE EXPRESSION; ICOSANOID METABOLISM; INTESTINAL DYSMOTILITY; INTESTINE MUSCLE; METABOLITE; MOUSE; MUSCLE CONTRACTILITY; NEWBORN; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WILD TYPE;

ANIMALS; BACTERIA; CHOLINERGIC AGENTS; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DINOPROSTONE; GASTROINTESTINAL TRANSIT; GENE EXPRESSION; INTESTINAL DISEASES; INTESTINE, SMALL; MICE; MICE, INBRED C57BL; MICE, INBRED CFTR; MICE, KNOCKOUT; MUSCLE CONTRACTION; MUSCLE, SMOOTH; PHOSPHOLIPASES A2;

BACTERIA (MICROORGANISMS); MUS;

EID: 84870912455     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3182638bf4     Document Type: Article

References (36)

1. Seidler U, Singh A, Chen M, et al. Knockout mouse models for intestinal electrolyte transporters and regulatory PDZ adaptors: new insights into cystic fibrosis, secretory diarrhoea and fructose-induced hypertension. Exp Physiol 2009;94:175-9.
2. Mueller C, Braag SA, Keeler A, et al. Lack of cystic fibrosis transmembrane conductance regulator in CD3+ lymphocytes leads to aberrant cytokine secretion and hyperinflammatory adaptive immune responses. Am J Respir Cell Mol Biol 2011;44:922-9.
3. Guo Y, Su M, McNutt MA, et al. Expression and distribution of cystic fibrosis transmembrane conductance regulator in neurons of the human brain. J Histochem Cytochem 2009;57:1113-20.
4. Pan J, Luk C, Kent G, et al. Pulmonary neuroendocrine cells, airway innervation, and smooth muscle are altered in Cftr null mice. Am J Respir Cell Mol Biol 2006;35:320-6.
5. Michoud MC, Robert R, Hassan M, et al. Role of the cystic fibrosis transmembrane conductance channel in human airway smooth muscle. Am J Respir Cell Mol Biol 2009;40:217-22.
6. Quinton PM. Cystic fibrosis: impaired bicarbonate secretion and mucoviscidosis. Lancet 2008;372:415-7.
7. Sbarbati A, Bertini M, Catassi C, et al. Ultrastructural lesions in the small bowel of patients with cystic fibrosis. Pediatr Res 1998;43:234-9.
8. Lojda Z, Jodl J. Jejunal mucosa in children with mucoviscidosis. Cesk Patol 1975;11:135-9.
9. Garcia MAS, Yang N, Quinton PM. Normal mouse intestinal mucus release requires cystic fibrosis transmembrane regulator-dependent bicarbonate secretion. J Clin Invest 2009;119:2613-22.
10. Norkina O, Burnett TG, De Lisle RC. Bacterial overgrowth in the cystic fibrosis transmembrane conductance regulator null mouse small intestine. Infect Immun 2004;72:6040-9.
11. Bruzzese E, Raia V, Gaudiello G, et al. Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration. Aliment Pharmacol Ther 2004;20:813-9.
12. Raia V, Maiuri L, De Ritis G, et al. Evidence of chronic inflammation in morphologically normal small intestine of cystic fibrosis patients. Pediatr Res 2000;47:344-50.
13. Werlin SL, Benuri-Silbiger I, Kerem E, et al. Evidence of intestinal inflammation in patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 2010;51:304-8.
14. Strandvik B. Fatty acid metabolism in cystic fibrosis. Prostaglandins Leukot Essent Fatty Acids 2010;83:121-9.
15. Dif F, Wu YZ, Burgel PR, et al. Critical role of cytosolic phospholipase a2{alpha} in bronchial mucus hyper-secretion in CFTR-deficient mice. Eur Respir J 2010;36:1120-30.
16. De Lisle RC, Meldi L, Flynn M, et al. Altered eicosanoid metabolism in the cystic fibrosis mouse small intestine. J Pediatr Gastroenterol Nutr 2008;47:406-16.
17. Chmiel JF, Konstan MW. Inflammation and anti-inflammatory therapies for cystic fibrosis. Clin Chest Med 2007;28:331-46.
18. Carlstedt-Duke J, Bronnegard M, Strandvik B. Pathological regulation of arachidonic acid release in cystic fibrosis: the putative basic defect. Proc Natl Acad Sci U S A 1986;83:9202-6.
19. Strandvik B, Svensson E, Seyberth HW. Prostanoid biosynthesis in patients with cystic fibrosis. Prostaglandins Leukot Essent Fatty Acids 1996;55:419-25.
20. Medjane S, Raymond B, Wu Y, et al. Impact of CFTR DeltaF508 mutation on prostaglandin E2 production and type IIA phospholipase A2 expression by pulmonary epithelial cells. Am J Physiol Lung Cell Mol Physiol 2005;289:L816-24.
21. Freedman SD, Blanco PG, Zaman MM, et al. Association of cystic fibrosis with abnormalities in fatty acid metabolism. N Engl J Med 2004;350:560-9.
22. Tirouvanziam R, Khazaal I, Peault B. Primary inflammation in human cystic fibrosis small airways. Am J Physiol Lung Cell Mol Physiol 2002;283:L445-51.
23. Fink J, Steer JH, Joyce DA, et al. Pro-inflammatory effects of Burkholderia cepacia on cystic fibrosis respiratory epithelium. FEMS Immunol Med Microbiol 2003;38:273-82.
24. Hodges CA, Cotton CU, Palmert MR, et al. Generation of a conditional null allele for Cftr in mice. Genesis 2008;46:546-52.
25. Hodges CA, Grady BR, Mishra K, et al. Cystic fibrosis growth retardation is not correlated with loss of Cftr in the intestinal epithelium. Am J Physiol Gastrointest Liver Physiol 2011;301:G528-36.
26. De Lisle RC, Sewell R, Meldi L. Enteric circular muscle dysfunction in the cystic fibrosis mouse small intestine. Neurogastroenterol Motil 2010;22:341-e87.
27. De Lisle RC. Altered transit and bacterial overgrowth in the cystic fibrosis mouse small intestine. Am J Physiol Gastrointest Liver Physiol 2007;293:G104-11.
28. Tai HH, Ensor CM, Tong M, et al. Prostaglandin catabolizing enzymes. Prostaglandins Other Lipid Mediat 2002;68-69:483-93.
29. Ganz T. Angiogenin: an antimicrobial ribonuclease. Nat Immunol 2003;4:213-4.
30. Hooper LV, Stappenbeck TS, Hong CV, et al. Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat Immunol 2003;4:269-73.
31. Malmberg EK, Noaksson KA, Phillipson M, et al. Increased levels of mucins in the cystic fibrosis mouse small intestine and modulator effects of the Muc1 mucin expression. Am J Physiol Gastrointest Liver Physiol 2006;291:G203-10.
32. De Lisle RC, Roach E, Jansson K. Effects of laxative and N-acetylcysteine on mucus accumulation, bacterial load, transit, and inflammation in the cystic fibrosis mouse small intestine. Am J Physiol Gastrointest Liver Physiol 2007;293:G577-84.
33. Hallberg K, Abrahamsson H, Dalenback J, et al. Gastric secretion in cystic fibrosis in relation to the migrating motor complex. Scand J Gastroenterol 2001;36:121-7.
34. Scott LD, Cahall DL. Influence of the interdigestive myoelectric complex on enteric flora in the rat. Gastroenterology 1982;82:737-45.
35. Yuan C, Sidhu RS, Kuklev DV, et al. Cyclooxygenase allosterism, fatty acid-mediated cross-talk between monomers of cyclooxygenase homodimers. J Biol Chem 2009;284:10046-55.
36. Andersson C, Al-Turkmani MR, Savaille JE, et al. Cell culture models demonstrate that CFTR dysfunction leads to defective fatty acid composition and metabolism. J Lipid Res 2008;49:1692-700.